amitriptyline neuropathy
Selected indexed studies
- Peripheral Neuropathy: A Review. (JAMA, 2026) [PMID:41247746]
- Diabetic peripheral neuropathy essentials: a narrative review. (Ann Palliat Med, 2023) [PMID:36786097]
- Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. (Lancet, 2022) [PMID:36007534]
_Worker-drafted node — pending editorial review._
Connections
amitriptyline neuropathy is a side effect of
Sources
- Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. (2022) pubmed
- Peripheral Neuropathy: A Review. (2026) pubmed
- Diabetic peripheral neuropathy essentials: a narrative review. (2023) pubmed
- Amitriptyline. (2026) pubmed
- Diabetic Peripheral Neuropathy: Prevention and Treatment. (2024) pubmed
- Chemotherapy-induced peripheral neuropathy: where are we now? (2019) pubmed
- Pregabalin and amitriptyline as first-line drugs among patients with painful peripheraldiabetic neuropathy: a systematic review and meta-analysis. (2024) pubmed
- Amitriptyline, Pregabalin and Duloxetine for Treatment of Painful Diabetic Peripheral Neuropathy. (2024) pubmed
- ARSACS. (1993) pubmed
- Neuropharmacology of Neuropathic Pain: A Systematic Review. (2024) pubmed